Evidence map›Paper›PMID 35003249›Full record

ArticleComputational intelligence and neuroscience2021

Sequence Fusion Algorithm of Tumor Gene Sequencing and Alignment Based on Machine Learning.

Chao Tang, Ling Luo, Yu Xu, Guobin Chen, Li Tang, Ying Wang, Yongzhong Wu, Xiaolong Shi

Abstract read
In one paragraph

Article in Computational intelligence and neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chao TangRadiation & Cancer Biology Laboratory, Radiation Oncology Center, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer, Institute & Chongqing Cancer Hospital, Chongqing 400030, China.
Ling LuoThe Department of Internal Medicine, Chongqing University Cancer Hospital & Chongqing Cancer, Institute & Chongqing Cancer Hospital, Chongqing 400030, China.
Yu XuCollege of Bioengineering, Chongqing University, Chongqing, China.
Guobin ChenChongqing Key Laboratory of Spatial Data Mining and Big Data Integration for Ecology and Environment, Chongqing Finance and Economics College, Chongqing 401320, China.ORCID https://orcid.org/0000-0002-2581-7290
Li TangRadiation & Cancer Biology Laboratory, Radiation Oncology Center, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer, Institute & Chongqing Cancer Hospital, Chongqing 400030, China.
Ying WangRadiation & Cancer Biology Laboratory, Radiation Oncology Center, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer, Institute & Chongqing Cancer Hospital, Chongqing 400030, China.
Yongzhong WuRadiation & Cancer Biology Laboratory, Radiation Oncology Center, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer, Institute & Chongqing Cancer Hospital, Chongqing 400030, China.ORCID https://orcid.org/0000-0001-8367-3347
Xiaolong ShiRadiation & Cancer Biology Laboratory, Radiation Oncology Center, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital & Chongqing Cancer, Institute & Chongqing Cancer Hospital, Chongqing 400030, China.ORCID https://orcid.org/0000-0002-0038-5049

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid development of DNA high-throughput testing technology, there is a high correlation between DNA sequence variation and human diseases, and detecting whether there is variation in DNA sequence has become a hot research topic at present. DNA sequence variation is relatively rare, and the establishment of DNA sequence sparse matrix, which can quickly detect and reason fusion variation point, has become an important work of tumor gene testing. Because there are differences between the current comparison software and mutation detection software in detecting the same sample, there are errors between the results of derivative sequence comparison and the detection of mutation. In this paper, SNP and InDel detection methods based on machine learning and sparse matrix detection are proposed, and VarScan 2, Genome Analysis Toolkit (GATK), BCFtools, and FreeBayes are compared. In the research of SNP and InDel detection with intelligent reasoning, the experimental results show that the detection accuracy and recall rate are better when the depth is increasing. The reasoning fusion method proposed in this paper has certain advantages in comparison effect and discovery in SNP and InDel and has good effect on swelling and pain gene detection.

Indexed as

High-Throughput Nucleotide SequencingNeoplasmsAlgorithmsHumansMachine LearningSequence Analysis, DNASoftware

Identifiers

PMID35003249
PMCPMC8741399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.